血管补片市场规模、份额及成长分析（按材料、应用及地区划分）－2026-2033年产业预测

预计到 2024 年，血管补片市场规模将达到 4.5258 亿美元，到 2025 年将达到 4.8924 亿美元，到 2033 年将达到 9.1228 亿美元，预测期（2026-2033 年）的复合年增长率为 8.1%。

慢性肾臟病(CKD) 的高发生率对医疗保健环境造成了重大影响，并且是多种疾病的危险因素，包括糖尿病、高血压和心血管疾病。 CKD 的特征是肾功能逐渐下降，这会损害人体调节体液、电解质和代谢废物的能力，从而导致严重的健康併发症。美国已有超过 3,700 万成年人被诊断出患有此病，因此迫切需要有效的治疗方法和介入措施。不断增长的患者群体凸显了对创新解决方案（例如血管补片）日益增长的需求，这些解决方案可以解决 CKD 相关併发症并改善患者预后。随着医疗保健提供者寻求更先进的治疗方案来控制 CKD併发症，血管补片市场预计将会成长。

全球血管补片市场按材料、应用和地区划分为三个部分。依材料划分，血管补片分为生物基血管补片和合成血管补片。依应用划分，血管补片分为颈动脉内膜剥离术、主动脉瘤、深部血管成形术和其他应用。依地区划分，血管补片市场分为北美、欧洲、亚太、拉丁美洲以及中东和非洲（MEA）。

血管补片市场成长要素

全球人口老化是血管补片市场成长的关键驱动因素。随着人口老化，罹患心血管疾病、高胆固醇、高血压、中风、癌症和动脉瘤等多种健康问题的风险日益增加。这种人口结构变化导致对医疗干预的需求不断增长，尤其是在心臟健康领域。老龄化与心血管健康下降之间的关联凸显了这一趋势的重要性，也凸显了开发血管补片等创新解决方案以应对人口老化带来的日益严峻的健康挑战的必要性，从而推动了市场发展。

血管补片市场的限制因素

血管补片市场成长面临的关键阻碍因素之一是产品召回频率的不断增加，这引发了人们对产品品质和安全性的担忧。例如，一些知名医疗公司也曾因可能危及病人安全的问题而召回血管补片。此类事件会引发医护人员和病患的焦虑，导致他们对产品的信任度下降。因此，这些挑战可能会对市场动态负面影响，损害消费者信心和整个产业的业绩，并最终抑制血管补片市场的预期成长。

血管补片市场趋势

血管补片市场呈现显着上升趋势，这主要得益于微创外科技术（尤其是经经皮冠状动脉绕道手术 (MIDCAB) 等心血管手术）的日益普及。微创外科技术的进步提高了手术安全性，改善了病患预后，降低了死亡率，进而推动了这项改变。此外，与现有心肺体外迴圈系统相容的冠状动脉血管支架等创新外科技术也推动了对血管移植片的需求。随着医疗机构日益重视以患者为中心的治疗方案和经济高效的解决方案，预计血管补片市场将迎来强劲增长，这反映了医疗行业向先进外科手术和改善患者照护方向发展的趋势。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究

全球血管补片市场规模（按材料和复合年增长率划分）（2026-2033 年）

• 生物衍生血管补片
• 合成血管补片

全球血管补片市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 颈动脉内膜剥离术
• 腹部主动脉血管瘤开放性修补术
• 血管绕道手术
• 先天性心臟疾病
• 其他用途

全球血管补片市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 门诊手术中心

全球血管补片市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Baxter International Inc.（USA）
• Terumo Corporation（Japan）
• Edwards Lifesciences Corporation（USA）
• Getinge AB（Sweden）
• B. Braun SE（Germany）
• LeMaitre Vascular, Inc.（USA）
• WL Gore & Associates, Inc.（USA）
• Artivion, Inc.（formerly CryoLife, Inc.）（USA）
• Aziyo Biologics, Inc.（USA）
• Vascudyne, Inc.（USA）
• Collagen Solutions Plc（UK）
• FOC Medical SA（Switzerland）
• Obex Medical Ltd.（New Zealand）
• Vascumed（Pty）Ltd.（South Africa）
• Celox Medical（UK）
• Biom'up（France）
• Hemovent GmbH（Germany）
• Kuros Biosciences AG（Switzerland）
• Medtronic plc（Ireland）
• Abbott Laboratories（USA）

结论与建议

Vascular Patches Market size was valued at USD 452.58 Million in 2024 and is poised to grow from USD 489.24 Million in 2025 to USD 912.28 Million by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The prevalence of chronic kidney disease (CKD) significantly impacts the healthcare landscape, underpinning risks for various conditions such as diabetes, hypertension, and cardiovascular diseases. CKD is characterized by a gradual decline in kidney function, impairing the body's capability to regulate fluids, electrolytes, and waste, which can create serious health complications. With over 37 million adults in the United States diagnosed with this condition, the demand for effective treatments and interventions is crucial. This rising patient population highlights the increasing need for innovative solutions, such as vascular patches, that can address complications associated with CKD and improve patient outcomes. The market for vascular patches is poised for growth as healthcare providers seek advanced treatment options for managing CKD's ramifications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vascular Patches market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vascular Patches Market Segments Analysis

The global Vascular Patches Market is segmented into three segments i.e. by Material, Application and Region. Based on material, the market is segmented into Biologic Vascular Patches, Synthetic Vascular Patches. Based on Application, the market is segmented into Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, Other Applications. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver of the Vascular Patches Market

The increasing global aging population serves as a crucial driver for the growth of the vascular patches market. As individuals age, they are more susceptible to a variety of health issues, including cardiovascular diseases, high cholesterol, hypertension, strokes, cancer, and aneurysms. This demographic shift leads to a greater demand for medical interventions, particularly in cardiac health. The correlation between advancing age and the decline in cardiovascular wellness underscores the importance of this trend, highlighting the need for innovative solutions like vascular patches to address the escalating health challenges associated with an older population, thereby fostering market development.

Restraints in the Vascular Patches Market

One significant factor that may hinder growth in the vascular patches market is the increasing frequency of product recalls, which raises concerns about quality and safety. For example, notable healthcare companies have faced instances where vascular patches were recalled due to issues that could jeopardize patient safety. These events create apprehensions among healthcare providers and patients alike, potentially leading to decreased trust in these products. Consequently, such challenges can adversely affect market dynamics, influencing consumer confidence and the overall performance of the industry, ultimately restraining the anticipated growth of the vascular patches market.

Market Trends of the Vascular Patches Market

The Vascular Patches market is experiencing a notable upward trend driven by the rising adoption of minimally invasive surgical techniques, particularly in cardiac procedures such as MIDCAB. This shift is motivated by the enhanced safety and improved patient outcomes associated with these methods, leading to lower mortality rates. The compatibility of innovative surgical techniques, including coronary artery stent grafts, with existing cardiopulmonary bypass systems further propels demand for vascular grafts. As healthcare providers increasingly prioritize patient-centered approaches and economical solutions, the market for vascular patches is poised for robust growth, reflecting a broader movement toward advanced surgical interventions and improved patient care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Vascular Patches Market Size by Material & CAGR (2026-2033)

• Market Overview
• Biologic Vascular Patches
• Synthetic Vascular Patches

Global Vascular Patches Market Size by Application & CAGR (2026-2033)

• Market Overview
• Carotid Endarterectomy
• Open Repair of Abdominal Aortic Aneurysm
• Vascular Bypass Surgery
• Congenital Heart Disease
• Other Applications

Global Vascular Patches Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers

Global Vascular Patches Market Size & CAGR (2026-2033)

• North America (Material, Application, End User)
  • US
  • Canada
• Europe (Material, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LeMaitre Vascular, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artivion, Inc. (formerly CryoLife, Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aziyo Biologics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascudyne, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collagen Solutions Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FOC Medical S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Obex Medical Ltd. (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascumed (Pty) Ltd. (South Africa)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celox Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biom'up (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemovent GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations